ADC Therapeutics

1 follower

‌

ADC Therapeutics is a clinical-stage oncology biotechnology company leading the development and commercialization of next-generation antibody drug conjugates (ADCs) with highly potent and targeted pyrrolobenzodiazepine (PBD) dimer technology.

Industries

Employees

201-500

Links

Org chart

Ameet Mallik

Collapse
Kimberly Pope
Chief People Officer
Patrick van Berkel
Chief Scientific Officer
Peter Graham
Chief Legal Officer
Jose Carmona
Chief Financial Officer
Kristen Harrington-Smith
Chief Commercial Officer
Mohamed Zaki
Chief Medical Officer
Jada Baijnath
Director Of Strategic Planning And Chief Of Staff
Jay Feingold
Chief Medical Officer And Senior Vice President
Stephen Dudek
Director, Global Strategy & Lifecycle Management
Jesse Stromeyer
Executive Director, Head Of Marketing
Niall McConnell
Head, Business Information Systems
Ruchi Mallya
Forecasting & Commercial Data Analytics
Jason Moss
Head, Chemical Development & Manufacturing

Board & advisors

Ron Squarer
Chairman
Peter Hug
Vice-Chairman & Lead Independent Director
Stephen Evans-Freke
Non-Executive Director
Viviane Monges
Non-Executive Director
Thomas Pfisterer
Non-Executive Director
Tyrell J. Rivers
Non-Executive Director
Victor Sandor
Non-Executive Director
Jean-Pierre Bizzari
Non-Executive Director
Bob Azelby
Non-Executive Director